Beam Therapeutics Inc. BEAM
25.81 USD +0.66 (+2.62%)
At closeNov 11, 2026, 4:25 PM EST
25.81 0.00 0.00%
After hours · Nov 11, 4:25 PM ET
24.68 Day range 26.07
20.23 52-week range 38.26
- YTD
- -6.89%
- 1 year
- +14.81%
BEAM revenue history
Revenue is income from the company’s ordinary business activities.
139,743,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 139,743,000 | 76,225,000 | 120.01% |
| FY 2024 | 2024-12-31 | 63,518,000 | -314,191,000 | -83.18% |
| FY 2023 | 2023-12-31 | 377,709,000 | 316,789,000 | 520.01% |
| FY 2022 | 2022-12-31 | 60,920,000 | 9,076,000 | 17.51% |
| FY 2021 | 2021-12-31 | 51,844,000 | 51,820,000 | 215916.67% |
| FY 2020 | 2020-12-31 | 24,000 | 6,000 | 33.33% |
| FY 2019 | 2019-12-31 | 18,000 | 18,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:12.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.